Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This double-blind crossover study aims to compare cognitive performance (e.g., working
memory, selective attention and cognitive flexibility) of children ages 6-18 years diagnosed
with ADHD of the combined type (ADHD-C) or inattentive-type (ADHD-IA) and currently on > 20
mg/day of psychostimulants (psychostimulants) on: a) their current dose of psychostimulants,
vs. b) a lower-dose of psychostimulants (half of their current dose).
The investigators hypothesize that the lower-dose psychostimulants will result in better
cognitive performance than moderate-to-high doses of psychostimulants.